A new study found that one in three young adults receive medication for opioid use disorder within 12 months of a non-fatal opioid overdose. The study, led by researchers at Boston Medical Center’s Grayken Center for Addiction, in collaboration with the Massachusetts Department of Public Health (DPH), shows which medications…
Alternative to ‘revolving door’ of opioid detox and relapse
In a first-ever randomized trial, patients at a short-term inpatient program began long-term outpatient treatment with buprenorphine before discharge, with better outcomes than detox patients. Three out of four people who complete an inpatient opioid withdrawal management program — commonly known as “detox” — relapse within a month, leading to…
Use Of Buprenorphine To Treat Opioid Addiction Proliferates In California
Buprenorphine, a relative newcomer in the treatment of opioid addiction, is growing in popularity among California doctors as regulatory changes, physician training and other initiatives make the medication more widely accessible. The rate of Medi-Cal enrollees who received buprenorphine nearly quadrupled from the end of 2014 to the third quarter…
Too Few People Who Survive Opioid Overdose Get Medication-Assisted Treatment
A new study concludes too few people who survive an opioid overdose receive medication-assisted treatment that will reduce the chance of another overdose. The study included more than 17,500 adults who survived an opioid overdose and found only about one-third received either buprenorphine (Suboxone), methadone or naltrexone (Vivitrol), HealthDay reports. Among people…
Methadone and buprenorphine reduce risk of death after opioid overdose
A National Institutes of Health-funded study found that treatment of opioid use disorder with either methadone or buprenorphine following a nonfatal opioid overdose is associated with significant reductions in opioid related mortality. The research, published today in the Annals of Internal Medicine, was co-funded by the National Institute on Drug Abuse…